ORLANDO — Combining an enzyme-inducing antiseizure medication with a direct-acting oral anticoagulant (DOAC) does not significantly increase the risk of thromboembolic events in patients with epilepsy ...
Long-term use of enzyme-inducing antiseizure medications (eiASMs) is linked to a significant increase in incident cardiovascular disease risk in patients with epilepsy, new research suggests. It's the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results